MERCK & CO., INC.
Collaborative Engagement on Access to Medicine and SDG3
62 members
A young executive was leaving the office late one evening, when he finds the CEO standing in front of a shredder with a piece of paper in his hand.
Collaboration details
Lorem Ipsum has been the industry standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Attachments
- anonymous_11881.txt Download
Engagement focus
Takeda Pharmaceutical Company Limited
Sanofi Aventis
PFIZER INC.
NOVO NORDISK A/S
Novartis AG
Merck KGaA
JOHNSON & JOHNSON
GlaxoSmithKline PLC
GILEAD SCIENCES, INC.
ELI LILLY AND COMPANY
Eisai Co., Ltd.
DAIICHI SANKYO COMPANY, LIMITED
BRISTOL-MYERS SQUIBB COMPANY
BAYER CORPORATION
ASTRAZENECA PLC
Astellas Pharma Inc.
ABBVIE INC.
Roche Holding AG
Created on
ESG theme
- Social
ESG sub-theme
- Human rights
Sector
- Health Care
Sustainable Development Goal
- 3 - Good health & well-being
Geography
- Global
Asset class
All